Adenocarcinoma of gallbladder and extrahepatic biliary tract
MONDO:0018536Adenocarcinoma of the gallbladder and extrahepatic biliary tract is a rare epithelial carcinoma, arising either in the gallbladder itself or from the epithelium lining the extrahepatic biliary tree, cystic duct and/or peribiliary gland, characterized by nonspecific symptoms, such as abdominal pain, jaundice and vomiting and sometimes mimicking benign biliary diseases. Chronic biliary epithelial inflammation (e.g. primary sclerosing cholangitis, cholelithiasis, choledocholithiasis, liver fluke infestation) is a major risk factor.
Also known as: adenocarcinoma of gallbladder and EBT, adenocarcinoma of the gallbladder and EBT, adenocarcinoma of the gallbladder and extrahepatic biliary tract
3276 clinical trials for this condition and its sub-types, 6 tagged with Adenocarcinoma of gallbladder and extrahepatic biliary tract itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Adenocarcinoma of gallbladder and extrahepatic biliary tract
-
Cholangiocarcinoma 311 trials · 367 incl. sub-types
1 sub-type
- Intrahepatic cholangiocarcinoma 154 trials · 176 incl. sub-types Sub-types →
Most studied deeper sub-types
-
Can a three-drug cocktail shrink advanced bile-duct tumors?
Disease control CompletedThis phase 2 trial is testing whether combining bevacizumab (a blood-vessel growth blocker) with nab-paclitaxel and an oral chemotherapy called S-1 can shrink tumors in people with advanced biliary tract adenocarcinoma that has worsened after initial treatment. About 32 participa…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug combo shows promise for Tough-to-Treat bile duct cancer
Disease control CompletedThis phase 2 trial tested a new chemotherapy combination (Nal-IRI with 5-FU and leucovorin) against a standard treatment (gemcitabine plus cisplatin) in 93 people with advanced biliary tract cancer that could not be removed by surgery. The study aimed to see which approach better…
Phase 2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC